Predicting Ventricular Arrhythmias in Patients With Ischemic Heart Disease: Clinical Application of the ECG-Derived QRS-T Angle
BACKGROUND—In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T an...
Saved in:
Published in | Circulation. Arrhythmia and electrophysiology Vol. 2; no. 5; pp. 548 - 554 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
American Heart Association, Inc
01.10.2009
Lippincott Williams & Wilkins |
Subjects | |
Online Access | Get full text |
ISSN | 1941-3149 1941-3084 1941-3084 |
DOI | 10.1161/CIRCEP.109.859108 |
Cover
Abstract | BACKGROUND—In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease.
METHODS AND RESULTS—ICD patients (n=412, 361 men; age, 63±11 years) with ischemic heart disease and a left ventricular ejection fraction ≤40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle ≤90° (n=124, 30%) with patients with a planar QRS-T angle >90° before device implantation. Furthermore, patients with a spatial QRS-T angle ≤100° (n=56, 14%) were compared with patients with a spatial QRS-T angle >100°, before implantation. For patients with a planar QRS-T angle >90° as compared with ≤90°, the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI, 1.1 to 5.2); a spatial QRS-T angle >100° was associated with an adjusted hazard ratio of 7.3 (95% CI, 1.0 to 53.8). Furthermore, a spatial QRS-T angle ≤100° exhibited a positive predictive value of 98% (95% CI, 95 to 100) for the prediction of an appropriate therapy-free follow-up.
CONCLUSIONS—A wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with ischemic heart disease. Furthermore, a spatial QRS-T angle ≤100° might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered. |
---|---|
AbstractList | In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease.BACKGROUNDIn patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease.ICD patients (n=412, 361 men; age, 63+/-11 years) with ischemic heart disease and a left ventricular ejection fraction < or = 40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle < or = 90 degrees (n=124, 30%) with patients with a planar QRS-T angle >90 degrees before device implantation. Furthermore, patients with a spatial QRS-T angle < or = 100 degrees (n=56, 14%) were compared with patients with a spatial QRS-T angle >100 degrees , before implantation. For patients with a planar QRS-T angle >90 degrees as compared with < or = 90 degrees , the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI, 1.1 to 5.2); a spatial QRS-T angle >100 degrees was associated with an adjusted hazard ratio of 7.3 (95% CI, 1.0 to 53.8). Furthermore, a spatial QRS-T angle < or = 100 degrees exhibited a positive predictive value of 98% (95% CI, 95 to 100) for the prediction of an appropriate therapy-free follow-up.METHODS AND RESULTSICD patients (n=412, 361 men; age, 63+/-11 years) with ischemic heart disease and a left ventricular ejection fraction < or = 40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle < or = 90 degrees (n=124, 30%) with patients with a planar QRS-T angle >90 degrees before device implantation. Furthermore, patients with a spatial QRS-T angle < or = 100 degrees (n=56, 14%) were compared with patients with a spatial QRS-T angle >100 degrees , before implantation. For patients with a planar QRS-T angle >90 degrees as compared with < or = 90 degrees , the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI, 1.1 to 5.2); a spatial QRS-T angle >100 degrees was associated with an adjusted hazard ratio of 7.3 (95% CI, 1.0 to 53.8). Furthermore, a spatial QRS-T angle < or = 100 degrees exhibited a positive predictive value of 98% (95% CI, 95 to 100) for the prediction of an appropriate therapy-free follow-up.A wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with ischemic heart disease. Furthermore, a spatial QRS-T angle < or = 100 degrees might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered.CONCLUSIONSA wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with ischemic heart disease. Furthermore, a spatial QRS-T angle < or = 100 degrees might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered. BACKGROUND—In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease. METHODS AND RESULTS—ICD patients (n=412, 361 men; age, 63±11 years) with ischemic heart disease and a left ventricular ejection fraction ≤40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle ≤90° (n=124, 30%) with patients with a planar QRS-T angle >90° before device implantation. Furthermore, patients with a spatial QRS-T angle ≤100° (n=56, 14%) were compared with patients with a spatial QRS-T angle >100°, before implantation. For patients with a planar QRS-T angle >90° as compared with ≤90°, the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI, 1.1 to 5.2); a spatial QRS-T angle >100° was associated with an adjusted hazard ratio of 7.3 (95% CI, 1.0 to 53.8). Furthermore, a spatial QRS-T angle ≤100° exhibited a positive predictive value of 98% (95% CI, 95 to 100) for the prediction of an appropriate therapy-free follow-up. CONCLUSIONS—A wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with ischemic heart disease. Furthermore, a spatial QRS-T angle ≤100° might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered. Background— In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease. Methods and Results— ICD patients (n=412, 361 men; age, 63 11 years) with ischemic heart disease and a left ventricular ejection fraction ≤40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle ≤90 (n=124, 30%) with patients with a planar QRS-T angle >90 before device implantation. Furthermore, patients with a spatial QRS-T angle ≤100 (n=56, 14%) were compared with patients with a spatial QRS-T angle >100 , before implantation. For patients with a planar QRS-T angle >90 as compared with ≤90 , the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI, 1.1 to 5.2); a spatial QRS-T angle >100 was associated with an adjusted hazard ratio of 7.3 (95% CI, 1.0 to 53.8). Furthermore, a spatial QRS-T angle ≤100 exhibited a positive predictive value of 98% (95% CI, 95 to 100) for the prediction of an appropriate therapy-free follow-up. Conclusions— A wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with ischemic heart disease. Furthermore, a spatial QRS-T angle ≤100 might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered. In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD therapy is relatively low, prompting for better risk stratification. The aim of this study was to assess the value of the QRS-T angle for prediction of ICD therapy and mortality in primary prevention patients with ischemic heart disease. ICD patients (n=412, 361 men; age, 63+/-11 years) with ischemic heart disease and a left ventricular ejection fraction < or = 40% were included. After device implantation, the occurrence of appropriate ICD therapy and mortality was noted. A survival analysis was performed comparing patients with a planar QRS-T angle < or = 90 degrees (n=124, 30%) with patients with a planar QRS-T angle >90 degrees before device implantation. Furthermore, patients with a spatial QRS-T angle < or = 100 degrees (n=56, 14%) were compared with patients with a spatial QRS-T angle >100 degrees , before implantation. For patients with a planar QRS-T angle >90 degrees as compared with < or = 90 degrees , the adjusted hazard ratio for the occurrence of appropriate device therapy was 2.4 (95% CI, 1.1 to 5.2); a spatial QRS-T angle >100 degrees was associated with an adjusted hazard ratio of 7.3 (95% CI, 1.0 to 53.8). Furthermore, a spatial QRS-T angle < or = 100 degrees exhibited a positive predictive value of 98% (95% CI, 95 to 100) for the prediction of an appropriate therapy-free follow-up. A wide QRS-T angle is a strong predictor of appropriate device therapy in primary prevention ICD recipients with ischemic heart disease. Furthermore, a spatial QRS-T angle < or = 100 degrees might be of value in the identification of patients in whom, although currently indicated, ICD treatment should be reconsidered. |
Author | Bax, Jeroen J. van Welsenes, Guido H. van Erven, Lieselot Scherptong, Roderick W.C. Schalij, Martin J. Borleffs, C Jan Willem Swenne, Cees A. Man, Sum-Che |
AuthorAffiliation | From the Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands |
AuthorAffiliation_xml | – name: From the Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands |
Author_xml | – sequence: 1 givenname: C surname: Borleffs middlename: Jan Willem fullname: Borleffs, C Jan Willem organization: From the Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands – sequence: 2 givenname: Roderick surname: Scherptong middlename: W.C. fullname: Scherptong, Roderick W.C. – sequence: 3 givenname: Sum-Che surname: Man fullname: Man, Sum-Che – sequence: 4 givenname: Guido surname: van Welsenes middlename: H. fullname: van Welsenes, Guido H. – sequence: 5 givenname: Jeroen surname: Bax middlename: J. fullname: Bax, Jeroen J. – sequence: 6 givenname: Lieselot surname: van Erven fullname: van Erven, Lieselot – sequence: 7 givenname: Cees surname: Swenne middlename: A. fullname: Swenne, Cees A. – sequence: 8 givenname: Martin surname: Schalij middlename: J. fullname: Schalij, Martin J. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22283768$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19843923$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1v1DAQhi1URD_gB3BBviBOWew4Tmxuq3RpV6rEUgocI8eZNAbHWWyHqif-OoZsQeKAJcsz8vOOZuY9RUducoDQc0pWlJb0db29rje7FSVyJbikRDxCJ1QWNGNEFEcPMS3kMToN4QshJRW0fIKOqRQFkzk7QT92Hjqjo3G3-BO46I2erfJ47f1wH4fRqICNwzsVTfoN-LOJA94GPcBoNL4E5SM-NwFUgDe4tsYZrSxe7_c2BdFMDk89jgPgTX2RnYM336HD768_ZDd47W4tPEWPe2UDPDu8Z-jj281NfZldvbvY1uurTBep60yRljJNWNfyvOg6TmXecyVa3WvSsZ7zlotKKcGF0FXLCFG54gmQIidQli07Q6-Wuns_fZshxGY0QYO1ysE0h6ZiBZEVqWQiXxzIuR2ha_bejMrfNw87S8DLA6BCGrb3ymkT_nB5ngtWlSJxdOG0n0Lw0P8tRZpf_jWLfymVzeJf0lT_aLSJv_cYvTL2v8piUd5NNoIPX-18B74ZQNk4NIQyVhWSZTkhCU8nS5dS9hNe2a4P |
CitedBy_id | crossref_primary_10_1016_j_ajem_2022_05_034 crossref_primary_10_33667_2078_5631_2023_22_36_42 crossref_primary_10_1016_j_jelectrocard_2015_04_014 crossref_primary_10_23736_S2724_5683_20_05166_X crossref_primary_10_1016_j_hrthm_2014_09_044 crossref_primary_10_1253_circj_CJ_24_0269 crossref_primary_10_7759_cureus_28506 crossref_primary_10_1016_j_jelectrocard_2017_02_008 crossref_primary_10_51847_GzeDdExlEH crossref_primary_10_1016_j_ijcard_2016_05_005 crossref_primary_10_4274_terh_galenos_2022_82335 crossref_primary_10_1186_s12872_023_03421_6 crossref_primary_10_1016_j_hroo_2025_02_005 crossref_primary_10_18621_eurj_1144126 crossref_primary_10_1016_j_jelectrocard_2013_09_003 crossref_primary_10_1016_j_jelectrocard_2022_09_001 crossref_primary_10_1007_s00380_019_01380_7 crossref_primary_10_1016_j_jelectrocard_2018_08_028 crossref_primary_10_1111_anec_70013 crossref_primary_10_1007_s12012_020_09579_1 crossref_primary_10_1161_JAHA_117_008160 crossref_primary_10_1007_s10840_018_0342_2 crossref_primary_10_1186_s12872_017_0631_1 crossref_primary_10_1681_ASN_2015080916 crossref_primary_10_5144_0256_4947_2012_372 crossref_primary_10_1093_europace_eus306 crossref_primary_10_1093_ndt_gfq247 crossref_primary_10_1016_j_jdiacomp_2016_12_001 crossref_primary_10_1016_j_jelectrocard_2016_10_001 crossref_primary_10_4103_0366_6999_187844 crossref_primary_10_1007_s00380_020_01585_1 crossref_primary_10_1016_j_jelectrocard_2013_07_005 crossref_primary_10_1016_j_jelectrocard_2022_10_008 crossref_primary_10_1093_ehjdh_ztae048 crossref_primary_10_1159_000509766 crossref_primary_10_1097_MCA_0000000000000935 crossref_primary_10_51582_interconf_19_20_04_2022_028 crossref_primary_10_1016_j_jelectrocard_2020_05_013 crossref_primary_10_1155_2020_6027405 crossref_primary_10_33678_cor_2023_030 crossref_primary_10_1016_j_jacc_2022_12_024 crossref_primary_10_1016_j_jelectrocard_2010_07_017 crossref_primary_10_1016_j_jelectrocard_2011_04_007 crossref_primary_10_1016_j_echo_2013_08_023 crossref_primary_10_2139_ssrn_4143707 crossref_primary_10_1109_ACCESS_2023_3256721 crossref_primary_10_1371_journal_pone_0171069 crossref_primary_10_1177_00912174231184759 crossref_primary_10_1016_j_jelectrocard_2019_09_028 crossref_primary_10_1017_S1047951116000640 crossref_primary_10_1016_j_amjcard_2013_01_294 crossref_primary_10_3390_diagnostics15020187 crossref_primary_10_3390_s22145414 crossref_primary_10_1016_j_jelectrocard_2017_12_038 crossref_primary_10_1097_MCA_0000000000001061 crossref_primary_10_1038_s41598_022_22501_9 crossref_primary_10_1002_clc_22707 crossref_primary_10_1371_journal_pone_0136174 crossref_primary_10_1016_j_jelectrocard_2014_11_009 crossref_primary_10_51262_ejtox_1206665 crossref_primary_10_1016_j_amjcard_2014_01_406 crossref_primary_10_1016_j_jelectrocard_2016_07_025 crossref_primary_10_1111_anec_12310 crossref_primary_10_1016_j_amjcard_2019_03_018 crossref_primary_10_1111_anec_12276 crossref_primary_10_1016_j_cellimm_2021_104427 crossref_primary_10_1016_j_jelectrocard_2010_03_009 crossref_primary_10_1002_clc_22549 crossref_primary_10_1016_j_jacep_2016_08_007 crossref_primary_10_1016_j_jelectrocard_2018_05_011 crossref_primary_10_1007_s00592_013_0483_9 crossref_primary_10_1093_ehjdh_ztad045 crossref_primary_10_34883_PI_2020_12_5_001 crossref_primary_10_1111_anec_12390 crossref_primary_10_1111_anec_13082 crossref_primary_10_1111_anec_12264 crossref_primary_10_1016_j_jelectrocard_2010_03_010 crossref_primary_10_1016_j_jelectrocard_2015_07_016 crossref_primary_10_1016_j_jelectrocard_2011_01_001 crossref_primary_10_1016_j_hrthm_2010_10_017 crossref_primary_10_1016_j_ijcard_2021_10_139 crossref_primary_10_3389_fped_2022_917730 crossref_primary_10_1260_2040_2295_4_2_167 crossref_primary_10_1111_anec_70062 crossref_primary_10_1111_pace_12365 crossref_primary_10_1016_j_bspc_2020_102305 crossref_primary_10_1016_j_jelectrocard_2020_10_009 crossref_primary_10_1093_europace_eur393 crossref_primary_10_1016_j_jelectrocard_2020_02_001 crossref_primary_10_1016_j_cvdhj_2023_11_003 crossref_primary_10_1016_j_jelectrocard_2023_02_003 crossref_primary_10_1007_s10840_011_9661_2 crossref_primary_10_1093_ndt_gft347 crossref_primary_10_1097_MD_0000000000032320 crossref_primary_10_1111_anec_12579 crossref_primary_10_1016_j_advms_2016_11_008 crossref_primary_10_1016_j_cardfail_2017_11_001 crossref_primary_10_1016_j_amjcard_2011_11_027 crossref_primary_10_3390_electronics13020326 crossref_primary_10_31832_smj_916225 crossref_primary_10_1111_anec_12051 crossref_primary_10_1007_s00059_020_04978_0 crossref_primary_10_1002_ehf2_12746 crossref_primary_10_28982_josam_641533 crossref_primary_10_1016_j_jelectrocard_2015_05_002 crossref_primary_10_1016_j_jelectrocard_2016_07_015 crossref_primary_10_1016_j_jelectrocard_2015_05_004 crossref_primary_10_1111_anec_12206 crossref_primary_10_1186_s12872_017_0696_x crossref_primary_10_1016_j_amjcard_2011_09_014 crossref_primary_10_1016_j_amjcard_2014_05_011 |
Cites_doi | 10.1016/0735-1097(95)00599-4 10.1016/j.amjcard.2005.04.046 10.1111/j.1540-8167.2006.00680.x 10.1016/j.hrthm.2005.08.031 10.1056/NEJM198308113090602 10.1016/j.jacc.2008.05.058 10.1016/j.hrthm.2006.05.025 10.1016/j.jelectrocard.2008.07.006 10.1056/NEJMra000650 10.1111/j.1540-8167.2006.00526.x 10.1056/NEJM199912163412503 10.1016/j.jelectrocard.2006.11.003 10.1161/circ.98.21.2334 10.1001/jama.295.16.1901 10.1161/circualtionaha.108.189742 10.1161/circulationaha.104.526673 10.1016/j.hrthm.2004.10.040 10.1056/NEJM199612263352601 10.1007/BF03085968 10.1161/circulationaha.107.733451 10.1056/NEJMoa013474 10.1056/NEJMoa043399 10.1161/circ.98.7.663 10.1161/circulationaha.107.189375 10.1016/S0195-668X(03)00203-3 10.1161/01.cir.0000129322.97266.f3 10.1016/j.hrthm.2004.02.009 10.1016/j.amjcard.2005.08.052 10.1056/NEJMoa032423 10.1161/01.cir.0000150390.04704.b7 10.1161/circ.102.11.1252 |
ContentType | Journal Article |
Copyright | 2009 American Heart Association, Inc. 2015 INIST-CNRS |
Copyright_xml | – notice: 2009 American Heart Association, Inc. – notice: 2015 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/CIRCEP.109.859108 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1941-3084 |
EndPage | 554 |
ExternalDocumentID | 19843923 22283768 10_1161_CIRCEP_109_859108 01337493-200910000-00011 |
Genre | Journal Article |
GroupedDBID | --- .XZ .Z2 18M 53G 5VS 6J9 AAAAV AAHPQ AAIQE AAJCS AARTV AASCR ABASU ABBUW ABDIG ABPXF ABVCZ ABXVJ ABXYN ABZAD ABZZY ACDDN ACEWG ACGFO ACILI ACWDW ACWRI ACXJB ACXNZ ADBBV ADGGA ADHPY ADNKB AEBDS AEETU AFBFQ AFDTB AFEXH AFNMH AFUWQ AGINI AHQNM AHQVU AHRYX AHVBC AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BQLVK C45 CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD EX3 F5P FCALG FL- GNXGY GQDEL H13 HLJTE IKREB IN~ IPNFZ KD2 KQ8 KQB L-C ODMTH ODZKP OHYEH OK1 OPUJH OUVQU OVD OVDNE OXXIT RAH RIG RLZ S4S TEORI TR2 TSPGW V2I W2D W3M W8F WOW ZZMQN AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM RHF 7X8 ADKSD |
ID | FETCH-LOGICAL-c4061-a0b13c03db524dd5192f5a8bcfc0d3f55b587aa8588c7b300a2a55a89820e66b3 |
ISSN | 1941-3149 1941-3084 |
IngestDate | Mon Sep 08 16:16:17 EDT 2025 Wed Feb 19 01:46:14 EST 2025 Mon Jul 21 09:14:50 EDT 2025 Thu Apr 24 23:11:01 EDT 2025 Tue Jul 01 01:19:06 EDT 2025 Fri May 16 03:46:54 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | ventricular arrhythmia Prognosis Arrhythmia QRS interval ischemic heart disease Cardiovascular disease Cardioversion Myocardial ischemia Male Epidemiology Myocardial disease Incidence Result Vascular disease Prevention Electrodiagnosis Primary Electrocardiography primary prevention Ventricular ejection Stratification Age Hazard implantable cardioverter-defibrillator Human Intensive cardiocirculatory care Critically ill Mortality Prediction Instrumentation therapy Method Coronary heart disease Left ventricle Angle Low Implanted Risk factor Hemodynamics Technique Predictive factor Application Defibrillator |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4061-a0b13c03db524dd5192f5a8bcfc0d3f55b587aa8588c7b300a2a55a89820e66b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 19843923 |
PQID | 734097079 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_734097079 pubmed_primary_19843923 pascalfrancis_primary_22283768 crossref_primary_10_1161_CIRCEP_109_859108 crossref_citationtrail_10_1161_CIRCEP_109_859108 wolterskluwer_health_01337493-200910000-00011 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-October |
PublicationDateYYYYMMDD | 2009-10-01 |
PublicationDate_xml | – month: 10 year: 2009 text: 2009-October |
PublicationDecade | 2000 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Circulation. Arrhythmia and electrophysiology |
PublicationTitleAlternate | Circ Arrhythm Electrophysiol |
PublicationYear | 2009 |
Publisher | American Heart Association, Inc Lippincott Williams & Wilkins |
Publisher_xml | – name: American Heart Association, Inc – name: Lippincott Williams & Wilkins |
References | e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 (e_1_3_2_23_2) 2006; 33 e_1_3_2_24_2 e_1_3_2_25_2 (e_1_3_2_26_2) 2005; 32 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_1_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_2_2 e_1_3_2_14_2 |
References_xml | – ident: e_1_3_2_5_2 doi: 10.1016/0735-1097(95)00599-4 – ident: e_1_3_2_17_2 doi: 10.1016/j.amjcard.2005.04.046 – ident: e_1_3_2_19_2 doi: 10.1111/j.1540-8167.2006.00680.x – ident: e_1_3_2_25_2 doi: 10.1016/j.hrthm.2005.08.031 – ident: e_1_3_2_4_2 doi: 10.1056/NEJM198308113090602 – ident: e_1_3_2_16_2 doi: 10.1016/j.jacc.2008.05.058 – ident: e_1_3_2_30_2 doi: 10.1016/j.hrthm.2006.05.025 – volume: 33 start-page: 849 year: 2006 ident: e_1_3_2_23_2 publication-title: Comput Cardiol – ident: e_1_3_2_27_2 doi: 10.1016/j.jelectrocard.2008.07.006 – ident: e_1_3_2_1_2 doi: 10.1056/NEJMra000650 – ident: e_1_3_2_18_2 doi: 10.1111/j.1540-8167.2006.00526.x – ident: e_1_3_2_8_2 doi: 10.1056/NEJM199912163412503 – ident: e_1_3_2_29_2 doi: 10.1016/j.jelectrocard.2006.11.003 – ident: e_1_3_2_3_2 doi: 10.1161/circ.98.21.2334 – ident: e_1_3_2_12_2 doi: 10.1001/jama.295.16.1901 – ident: e_1_3_2_11_2 doi: 10.1161/circualtionaha.108.189742 – ident: e_1_3_2_15_2 doi: 10.1161/circulationaha.104.526673 – ident: e_1_3_2_21_2 doi: 10.1016/j.hrthm.2004.10.040 – ident: e_1_3_2_9_2 doi: 10.1056/NEJM199612263352601 – ident: e_1_3_2_28_2 doi: 10.1007/BF03085968 – ident: e_1_3_2_22_2 doi: 10.1161/circulationaha.107.733451 – volume: 32 start-page: 515 year: 2005 ident: e_1_3_2_26_2 publication-title: Comput Cardiol – ident: e_1_3_2_10_2 doi: 10.1056/NEJMoa013474 – ident: e_1_3_2_6_2 doi: 10.1056/NEJMoa043399 – ident: e_1_3_2_14_2 doi: 10.1161/circ.98.7.663 – ident: e_1_3_2_31_2 doi: 10.1161/circulationaha.107.189375 – ident: e_1_3_2_20_2 doi: 10.1016/S0195-668X(03)00203-3 – ident: e_1_3_2_2_2 doi: 10.1161/01.cir.0000129322.97266.f3 – ident: e_1_3_2_24_2 doi: 10.1016/j.hrthm.2004.02.009 – ident: e_1_3_2_32_2 doi: 10.1016/j.amjcard.2005.08.052 – ident: e_1_3_2_7_2 doi: 10.1056/NEJMoa032423 – ident: e_1_3_2_13_2 doi: 10.1161/01.cir.0000150390.04704.b7 – ident: e_1_3_2_33_2 doi: 10.1161/circ.102.11.1252 |
SSID | ssj0061816 |
Score | 2.2882445 |
Snippet | BACKGROUND—In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias... Background— In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias... In patients with primary prevention implantable cardioverter-defibrillators (ICDs), the incidence of life-threatening ventricular arrhythmias resulting in ICD... |
SourceID | proquest pubmed pascalfrancis crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 548 |
SubjectTerms | Arrhythmias, Cardiac - etiology Arrhythmias, Cardiac - mortality Arrhythmias, Cardiac - physiopathology Arrhythmias, Cardiac - prevention & control Biological and medical sciences Cardiac dysrhythmias Cardiology. Vascular system Cardiovascular system Coronary heart disease Defibrillators, Implantable Electrocardiography - methods Female Heart Humans Investigative techniques of hemodynamics Investigative techniques, diagnostic techniques (general aspects) Male Medical sciences Middle Aged Myocardial Ischemia - complications Predictive Value of Tests Primary Prevention Proportional Hazards Models Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Survival Analysis |
Title | Predicting Ventricular Arrhythmias in Patients With Ischemic Heart Disease: Clinical Application of the ECG-Derived QRS-T Angle |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=01337493-200910000-00011 https://www.ncbi.nlm.nih.gov/pubmed/19843923 https://www.proquest.com/docview/734097079 |
Volume | 2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB6FIiEkhFhLWKo5cCJy8L5wK1G6QFtKSNTcrJnxmFhN7chxQHDhD_EjebPYcdSI7WJFo3HGzvsy85bvvYfQS0qcQPBwDc4c33BDTo2IeZZBmcldDkcKZcI1cHrmH03cd1Nv2un8bLGWVhXts-9b80r-R6owBnIVWbL_INnmS2EAPoN84QoShutfyfi8FGEWSVwWtEXpyyNlj5Tl7Fs1u8qIIomr0qk6jy0Dc1YS4kUr66oO0AjHQJMk2Qpq1xSC4eDQSOCVvoB--nH0yRj3SP55vlnnICuZ7gXW7-03jyCjE7rZjnSjbPjx3xblnKeKuigou5LFM9fuZBkfAkwtKs0bHonGbRm77F2snbun2oO7ujIGswalIivrQhz7uhPB4SpLCp2IUfs4ooYtV2_LkSu8ZKqZXJ9vGdN7ud2CrNfalz1VzvP6eeGL82JwPBoMz0Vlrb4o52eG68OxJgScfYgPJicn8Xg4Hd9AN-0ANDWhgh-_r899H4Atc9nq59IxdFji9bUFNrSgOwuyBOmmqpPKNlMH5nwtBHtieSmTJ1oq0PgeuqttF7yvgHgfdXj-AN061eyMh-jHGo-4hUfcwiPOclzjEQs84hqPWOIRazy-wTUacQuNuEgxoBG30IglGrFE4yM0ORiOB0eGbvBhMKFHGsSklsNMJ6Ge7SYJGBN26pGQspSZiZN6HvXCgJDQC0MWUMc0iU08mBCB2sp9nzqP0U5e5PwJwsT3eEJs36Kh5TJCojQkKU0iTnhoBYx3kVn_4DHT1e9FE5Z5LK1g34qVjAQjI1Yy6qJXzS0LVfrld5P3NqTY3GHL-lI-TMC1WGPYwUVYjuS8WC3jwBE158wg6qJdJe71clEIBoPtdJGxIf9YJUnHYL85gRs5YleMZKTOkEbe0z8v9gzdXv_TnqOdqlzxF6BfV3RPwvoXYmHUIg |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predicting+ventricular+arrhythmias+in+patients+with+ischemic+heart+disease%3A+clinical+application+of+the+ECG-derived+QRS-T+angle&rft.jtitle=Circulation.+Arrhythmia+and+electrophysiology&rft.au=Borleffs%2C+C+Jan+Willem&rft.au=Scherptong%2C+Roderick+W+C&rft.au=Man%2C+Sum-Che&rft.au=van+Welsenes%2C+Guido+H&rft.date=2009-10-01&rft.issn=1941-3084&rft.eissn=1941-3084&rft.volume=2&rft.issue=5&rft.spage=548&rft_id=info:doi/10.1161%2FCIRCEP.109.859108&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1941-3149&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1941-3149&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1941-3149&client=summon |